Amgen (AMGN): Denosumab Prostate Cancer Trial Meets Goals
2/9/2010
More...
|
Chelsea Therapeutics, Inc. (CHTP) Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program
2/9/2010
More...
|
Nymox Pharmaceutical (NYMX) Provides Update on Pivotal Phase 3 Trials for BPH Drug
2/9/2010
More...
|
Dynavax Technologies Corporation (DVAX) Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
2/9/2010
More...
|
Anthera Pharmaceuticals, Inc. Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study
2/8/2010
More...
|
Keryx Biopharmaceuticals (KERX) Responds to Erroneous Report About Planned Phase III Study for Patients With Colorectal Cancer
2/8/2010
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Announces Positive Results From Second Fidaxomicin Phase 3 Study in Patients With Clostridium Difficile Infection
2/5/2010
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Reports Encouraging Preliminary Data on BMN 110 for MPS IVA
2/5/2010
More...
|
Solvay Pharmaceuticals, Inc. Release: CREON(R) (Pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption in Children with Cystic Fibrosis, Study in Clinical Therapeutics Reports
2/5/2010
More...
|
Protalix Biotherapeutics Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Network
2/4/2010
More...
|
Shire plc to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network
2/3/2010
More...
|
AEterna Zentaris (AEZS) Partner Keryx Biopharmaceuticals (KERX) Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer
2/3/2010
More...
|
Neurosearch A/S (NEUR.CO) Announces Positive Top-line Results from Phase III Huntexil(R) Study in Huntington's Disease
2/3/2010
More...
|
Medivation, Inc. (MDVN): Mystery Medicine for Alzheimer's May Yield Advance for Pfizer Inc. (PFE)
2/2/2010
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Says FDA Agrees on Blood Cancer Drug Trial Design
2/2/2010
More...
|
Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)
2/2/2010
More...
|
LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition
2/1/2010
More...
|
MedImmune Release: Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
1/29/2010
More...
|
Basilea Pharmaceutica's Antifungal Isavuconazole Passed Phase III Clinical Trial Futility Analysis
1/29/2010
More...
|
Vical Incorporated (VICL) Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma
1/28/2010
More...
|
INSYS Therapeutics Announces Completion of Efficacy Trial for Fentanyl Sublingual Spray
1/26/2010
More...
|
Myriad Genetics, Inc. (MYGN) Study Reveals Patients Receive Suboptimal Dosing With Chemotherapy Regimens of FOLFOX6 and FOLFOX6 Plus Avastin
1/26/2010
More...
|
Medifocus Announces FDA Update for Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer: Files Response to Two Remaining Questions
1/26/2010
More...
|
China Aoxing Pharmaceutical Corp. (CAXG) Announces Successful Completion of Phase III Registration Clinical Study of Tilidine for Moderate to Severe Pain
1/25/2010
More...
|
Affymax, Inc. (AFFY) Completes Treatment and Last Patient Follow-up in Phase 3 Program for Investigational Drug, Hematide(TM), to Treat Anemia in Chronic Renal Failure
1/25/2010
More...
|
CureMark Enrolling Patients In Phase III Autism Trials At Ten Sites
1/25/2010
More...
|
Analysis of Marshall Edwards, Inc. (NVGN)'s OVATURE Trial to Proceed Following Database Lock
1/22/2010
More...
|
Pfizer Inc. (PFE)'s Kidney Drug Also Slows Pancreatic Cancer
1/22/2010
More...
|
EMD Serono, Inc.: Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
1/21/2010
More...
|
BioNumerik Pharmaceuticals, Inc. Initiates Treatment of Patients in Global Phase III Clinical Trial of Tavocept(TM)
1/21/2010
More...
|
Agennix Inc. Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally
1/21/2010
More...
|
Inspire Pharmaceuticals, Inc. (ISPH) Eye Drug Fails in Late-Stage Trial; Says Drug Did Not Meet Main Goal
1/21/2010
More...
|
Merck & Co., Inc. (MRK) HIV Drug from Schering-Plough Corporation (SGP) Merger Fails Trials
1/21/2010
More...
|
Depomed, Inc. (DEPO) Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
1/19/2010
More...
|
DURECT Corporation (DRRX) Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial BESST (Bupivacaine Effectiveness and Safety in SABER(TM) Trial) Targets Post-Surgical Pain
1/19/2010
More...
|
Centocor Ortho Biotech Inc. Says STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis
1/14/2010
More...
|
Celgene (CELG) (JOBS) Says Cancer Drug Revlimid Meets Trial Goal
1/13/2010
More...
|
Medifocus Announces Positive Clinical Results of Its Breast Cancer Treatment Studies Published in Annals of Surgical Oncology: Planning to Begin Phase III In Early 2010
1/12/2010
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Completes Enrollment in Second of Two Phase 3 Pivotal Trials for Apaziquone in Non-Muscle Invasive Bladder Cancer
1/12/2010
More...
|
Spherix (SPEX) Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose
1/12/2010
More...
|
Vion Pharmaceuticals (VION) Announces Filing of Special Protocol Assessment for Onrigin(TM)
1/12/2010
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) and Sigma-Tau Group Announce Positive Preliminary Results in Clinical Study Examining ZADAXIN'S Ability to Enhance Response to H1N1 Vaccine
1/12/2010
More...
|
Vical Incorporated (VICL) Says PAD Drug Gets Nod for Late Stage Trial
1/12/2010
More...
|
InterMune, Inc. (ITMN) Provides Program Update and 2010 Milestones for RG7227 (ITMN-191)
1/11/2010
More...
|
Amarin Corporation PLC (AMRN) Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease
1/11/2010
More...
|
VIVUS, Inc. (VVUS) Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes
1/11/2010
More...
|
MAP Pharmaceuticals, Inc. (MAPP) (JOBS) Says FDA Waives Second Trial for Migraine Drug
1/11/2010
More...
|
Plexxikon Inc. Announces First Patient Dosed in Phase 3 Trial of PLX4032 (RG7204) for Metastatic Melanoma
1/8/2010
More...
|
Tolerx, Inc. Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab
1/7/2010
More...
|
Novelos Therapeutics, Inc. Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
1/7/2010
More...
|
Sopherion Therapeutics, Inc. Receives FDA Fast Track Designation for Myocet in Metastatic Breast Cancer
1/7/2010
More...
|
Almirall, Forest Laboratories, Inc. (FRX) (JOBS) Say Positive Results on Lung Drug
1/7/2010
More...
|
BioVex Announces Broadened Inclusion Criteria in Phase 3 Melanoma Study; OncoVEX to be Evaluated in First Line Patients and Those Previously Treated
1/6/2010
More...
|
OncoMethylome Sciences S.A. to Perform MGMT Testing in Roche (RHHBY) Phase III Study of Avastin for Glioblastoma
1/6/2010
More...
|
Keryx Biopharmaceuticals (KERX) Announces Special Protocol Assessment Agreement with FDA for Phase 3 Registration Program of Zerenex in the Treatment of Hyperphosphatemia
1/5/2010
More...
|
Icon Bioscience Initiates Phase 2/3 Pivotal Clinical Study of Novel Ophthalmic Drug Candidate
1/5/2010
More...
|
D-Pharm Ltd. Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
1/4/2010
More...
|
Dr. Reddy's Laboratories, Inc. (RDY)'s and Rheoscience A/S Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593)
1/4/2010
More...
|
Novelos Therapeutics, Inc. Study Patients Continue to Live Longer as Pfizer Inc. (PFE) (JOBS) Stops Lung Cancer Study
1/4/2010
More...
|
Pfizer Inc. (PFE) (JOBS) Ends Late-stage Lung-Cancer Study; Analysis Showed it Would Miss Main Goal
12/30/2009
More...
|
Vion Pharmaceuticals (VION) Announces FDA Conclusion; HOVON Trial As Designed Does Not Gain SPA Agreement
12/30/2009
More...
|
Santarus Inc. (SNTS) Submits IND for Phase III Clinical Testing of Rifamycin SV MMX in Travelers' Diarrhea
12/30/2009
More...
|
AstraZeneca PLC (AZN) (JOBS) Replies to US Regulator on Motavizumab
12/28/2009
More...
|
Vical Incorporated (VICL)'s Late-Stage Trial Gets Positive Review
12/28/2009
More...
|
LifeCycle Pharma Submits the Phase 3 Protocol for LCP-Tacro(TM) (De No Kidney) to the FDA
12/23/2009
More...
|
Alimera Sciences Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
12/23/2009
More...
|
pSivida Corp (PSDV)'s Eye Therapy Meets Late-Stage Goal
12/23/2009
More...
|
Positive Results for LEO Pharma's Phase III Actinic (Solar) Keratosis Trials on the Face and Scalp
12/22/2009
More...
|
Preliminary Results in Clinuvel's Phase III Porphyria Trial
12/21/2009
More...
|
Actelion Ltd. (ALIOF.PK) (JOBS) Almorexant Meets Target; Flags Safety Woes
12/21/2009
More...
|
Cardiome Pharma Corp. (COM.TO) Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
12/18/2009
More...
|
Ligand Pharmaceuticals Inc. (LGND) Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
12/18/2009
More...
|
Roche (RHHBY) (JOBS), Ipsen (JOBS) Diabetes Drug Meets Goals in Studies
12/17/2009
More...
|
Celsion Corporation (CLN) and the American Liver Foundation Launch CME Accredited Webcast Featuring Recent Advances in the Treatment of Hepatocellular Carcinoma and the ThermoDox(R) Phase III Heat Study
12/17/2009
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
12/17/2009
More...
|
AEterna Zentaris (AEZS) Partner, Keryx Biopharmaceuticals (KERX), Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
12/16/2009
More...
|
ThromboGenics NV Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
12/16/2009
More...
|
Gilead Sciences, Inc. (GILD) (JOBS) Heart Drug Disappoints, Program Likely Dropped; Company Says Pivotal Phase of Study Missed Main Goals
12/15/2009
More...
|
Chelsea Therapeutics, Inc. (CHTP) Granted Approval to Change the Primary Endpoint and Increase Enrollment in Droxidopa Pivotal Study 301
12/15/2009
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Provides Update on Meeting With FDA to Discuss Pivotal Study Design for Sapacitabine
12/15/2009
More...
|
Roche Holding AG (RHHBF.PK) (JOBS) Restarts Phase III Avastin Clinical Trial
12/14/2009
More...
|
Diamyd Medical AB Vaccine Approved for Studies in Children Down to 3 Years of Age in the U.S.
12/14/2009
More...
|
Chelsea Therapeutics, Inc. (CHTP) Reports Subgroup Analysis of 44 Parkinson's Patients in Study 302 Shows Highly Statistically Significant Benefits of Droxidopa Therapy
12/14/2009
More...
|
Celsion Corporation (CLN) Announces Treatment of First Patient in China in Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
12/14/2009
More...
|
Neoprobe Corporation (NEOP) Researchers Present Phase 3 Results of Lymphoseek
12/11/2009
More...
|
GlaxoSmithKline (GSK) Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer
12/11/2009
More...
|
AstraZeneca PLC (AZN) Release: Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer
12/11/2009
More...
|
Published Data Demonstrate Arena Pharmaceuticals, Inc. (ARNA) Lorcaserin Has Low Abuse Potential
12/11/2009
More...
|
Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at a Tulane Cancer Center, New Orleans
12/11/2009
More...
|
Roche (RHHBY) (JOBS) Unit Genentech (South SF) (RHHBY) (JOBS) and Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) Meet Primary Endpoint on Phase III Study into Rheumatoid Arthritis Treatment
12/11/2009
More...
|
BioAlliance Pharma: Breakthrough Positive Phase III Results With Acyclovir Lauriad(R) Primary And Secondary Endpoints Met – Final Results
12/10/2009
More...
|
Johnson & Johnson (JNJ)'s (JOBS) Once-monthly INVEGA SUSTENNA Not Inferior to Bi-weekly RISPERDAL CONSTA
12/10/2009
More...
|
Emisphere Technologies, Inc. (EMIS) Reports DMC Recommendation to Proceed with Phase 3 Clinical Trials with Oral Calcitonin for Osteoporosis and Osteoarthritis
12/10/2009
More...
|
Unigene Laboratories, Inc. (UGNE) Release: Independent Advisory Committee Recommends Continuation of Phase III Oral Calcitonin Studies for Osteoporosis and Osteoarthritis
12/10/2009
More...
|
Merck KGaA (MKGAF.PK) Starts Stimuvax Phase III Study INSPIRE in Asian Patients with Advanced NSCLC
12/10/2009
More...
|
AVANIR Pharmaceuticals (AVNR) Presents Zenvia Phase III Results in Amyotrophic Lateral Sclerosis Patient Cohort at the International Symposium on ALS/MND
12/9/2009
More...
|
GlaxoSmithKline (GSK) (JOBS) Starts New Trial on Clogged Arteries Drug
12/9/2009
More...
|
Repligen Corporation (RGEN) Pancreatic Imaging Agent Does Not Meet Goal
12/9/2009
More...
|
Gentium S.p.A. Announces Final Clinical Trial Results for Defibrotide Presented at the American Society of Hematology Conference
12/8/2009
More...
|
Genzyme Corporation (GENZ) Phase 3 Trial of Campath/Fludara Combination Shows Potential Benefit in Second-Line CLL
12/8/2009
More...
|
Neoprobe Corporation (NEOP) Files Phase 3 Report With FDA
12/8/2009
More...
|
Novartis Corporation (NVS)'s (JOBS) Tasigna Prevents Leukaemia Progression
12/8/2009
More...
|
Millennium: The Takeda Oncology Company Release: VELCADE(R) (Bortezomib) for Injection Based Therapy Delivers Sustained Overall Survival Advantage in Patients with Previously Untreated Multiple Myeloma
12/8/2009
More...
|
Genentech (South SF) (RHHBY) And Biogen Idec, Inc. (California) (BIIB) Release: Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
12/8/2009
More...
|
AEterna Zentaris (AEZS) Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia; Study Z-036 Did Not Reach Primary Endpoint
12/7/2009
More...
|
Stallergenes, S.A. (GENP.PA): Oralair: Very Positive 3-Year Results of the Long-Term Study
12/7/2009
More...
|
Millennium: The Takeda Oncology Company's VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
12/7/2009
More...
|
Celsion Corporation (CLN) Provides Update on Progress of ThermoDox(R) Phase III Study for Primary Liver Cancer
12/3/2009
More...
|
Cosmo Pharmaceuticals S.p.A. Reports Completion Of Enrolment In Phase III EU Study Of Budesonide MMX(R) For Ulcerative Colitis
12/3/2009
More...
|
Roche Holding AG (RHHBF.PK) (JOBS) Says Diabetes Drug Better Than Merck & Co., Inc. (MRK)'s (JOBS) Januvia
12/2/2009
More...
|
Ipsen's (JOBS) Partner Roche (RHHBY) (JOBS) Announces That Taspoglutide Meets Its Primary Endpoints in Head-to-Head Study with Sitagliptin (Januvia®) and versus Placebo
12/2/2009
More...
|
Pacira Pharmaceuticals, Inc. Announces Results of Another Positive Phase III Trial in Post Operative Pain EXPAREL(TM)
12/2/2009
More...
|
Cell Therapeutics, Inc. (CTIC): New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology
12/2/2009
More...
|
AEterna Zentaris (AEZS)' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma
12/2/2009
More...
|
CEL-SCI (CVM) Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
12/1/2009
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Completion of Enrollment in One Apaziquone Phase 3 Pivotal Trial for Bladder Cancer Ahead of Schedule
11/30/2009
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
11/30/2009
More...
|
QRxPharma Pty Ltd. Initiates Pivotal Phase 3 Study of MoxDuo(TM)IR for Moderate to Severe Acute Pain
11/30/2009
More...
|
Sucampo Pharmaceuticals, Inc. Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG
11/25/2009
More...
|
Genzyme Corporation (GENZ) Ends Development of Kidney Treatment, Renvela's Successor
11/25/2009
More...
|
Cephalon, Inc. (CEPH) Delays Ception Deal After Mixed Drug Data
11/24/2009
More...
|
Genta Incorporated (GETA.OB)'s Genasense(R) Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
11/20/2009
More...
|
Roche (RHHBY)'s (JOBS) Actemra Successful in Arthritis Study; Meets Primary Endpoint in Phase III Study
11/20/2009
More...
|
Pozen, Inc. (POZN) Announces Start of Enrollment For PA32540 Phase 3 Program
11/20/2009
More...
|
Delcath Systems, Inc. (DCTH) Reports Substantial Progress Recent Follow-On Public Offering Provides Resources to Execute Plan Active Negotiations with Potential International Partners Continuing Phase III Study Enrollment Completed Executive Management Team Completed
11/19/2009
More...
|
VIVUS, Inc. (VVUS) Says Erectile Dysfunction Trial Meets Goals
11/19/2009
More...
|
Clinical Data, Inc. Initiates Phase III Trial of Stedivaze for Cardiac Stress Testing
11/18/2009
More...
|
US FDA Wants Panel to Probe Pfizer Inc. (PFE) (JOBS) Vaccine Efficacy
11/18/2009
More...
|
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Announce Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at American Heart Association
11/18/2009
More...
|
Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Cholesterol Drug Meets All Goals of Key Trial
11/17/2009
More...
|
Boehringer Ingelheim Corporation (JOBS) Drug Shown to Kindle Female Sex Drive
11/16/2009
More...
|
The Medicines Company (MDCO)'s Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patient Outcomes Following PCI
11/16/2009
More...
|
Aegera Therapeutics Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile
11/16/2009
More...
|
Alkermes (ALKS) Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
11/16/2009
More...
|
Genta Incorporated (GETA.OB) Announces Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
11/16/2009
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Cancer Drug Misses Study Goal; Shares Plunge
11/16/2009
More...
|
Cerus Corporation (CERS) (JOBS) Stock Trading Halted; FDA Blood Products Advisory Committee to Review and Discuss Proposed Phase III Clinical Trial Design for the INTERCEPT Blood System
11/16/2009
More...
|
Eurand: Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic Insufficiency
11/13/2009
More...
|
Merck & Co., Inc. (MRK) Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor
11/13/2009
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Completes Enrollment in Second Fidaxomicin Phase 3 Clinical Trial in Patients With Clostridium difficile Infection
11/12/2009
More...
|
Bend Memorial Clinic Pursues Recruitment in Lung Cancer Trial
11/12/2009
More...
|
Theratechnologies Inc. (TH.TO) Presents Combined Phase 3 Clinical Results at European AIDS Conference
11/12/2009
More...
|
Affymax, Inc. (AFFY) Announces Completion of Final Scheduled Data Monitoring Committee Review of Phase 3 Hematide Program
11/11/2009
More...
|
AVANIR Pharmaceuticals (AVNR) Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension
11/10/2009
More...
|
Labopharm (DDS.TO)'s Novel Trazodone Formulation Subject of Publication in Peer-Reviewed Medical Journal
11/10/2009
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI)
11/9/2009
More...
|
Genmab A/S (GEN.CO) Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL
11/9/2009
More...
|
Ikano Therapeutics Receives Orphan Drug Designation for Epilepsy Drug
11/9/2009
More...
|
Dyax Corp. (DYAX)'s DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
11/9/2009
More...
|
Dong-A PharmTech Announces Start of Phase III Trials for Udenafil, Its New Erectile Dysfunction Drug Under Development
11/6/2009
More...
|
Amgen (AMGN) (JOBS) Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer; Fails to Meet Secondary Endpoint of Overall Survival
11/5/2009
More...
|
ERYtech Pharma Starts its Pivotal Clinical Trial for GRASPA(R) in Acute Lymphoblastic Leukaemia
11/5/2009
More...
|
Inspire Pharmaceuticals, Inc. (ISPH) Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
11/4/2009
More...
|
BioAlliance Pharma Presents Additional US Pivotal Phase III Results on Loramyc(TM) (Miconazole Lauriad(R)) at the 47Th Annual Meeting of the IDSA
11/4/2009
More...
|
BioAlliance Pharma Presents Additional US Pivotal Phase III results on Loramyc(TM) at the 47th Annual Meeting of the IDSA
11/4/2009
More...
|
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer
11/4/2009
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) Provides Details On GlaxoSmithKline (GSK)'s Pivotal Malaria Vaccine Trial With QS-21 Adjuvant
11/4/2009
More...
|
World's Largest Malaria Vaccine Trial Now Underway In 7 African Countries, GlaxoSmithKline Biologicals (GSK) Study
11/3/2009
More...
|
Nabi Biopharmaceuticals (NABI) Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
11/3/2009
More...
|
Ironwood and Forest Laboratories, Inc. (FRX) (JOBS) Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation; Top-line Results Show Each Trial Met Primary and All Secondary Endpoints
11/3/2009
More...
|
Pfizer Inc. (PFE) And Medivation, Inc. (MDVN) Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease
11/3/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS), GlaxoSmithKline (GSK) Lupus Drug Works in 2nd Trial
11/2/2009
More...
|
Eisai Inc. (ESALF.PK) (JOBS): Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
11/2/2009
More...
|
Optimer Pharmaceuticals, Inc. (OPTR): Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
11/2/2009
More...
|
Shire plc Reports Tolerability and Clinical Effects Results of Daytrana(R)
11/2/2009
More...
|
Schering-Plough Corporation (SGP): Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
11/2/2009
More...
|
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical(TM) Therapy
11/2/2009
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Reviews American Association for the Study of Liver Diseases Annual Meeting
11/2/2009
More...
|
Gilead Sciences, Inc. (GILD) Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) For Chronic Hepatitis B
11/2/2009
More...
|
YM BioSciences (YM.TO) Reports Positive Nimotuzumab Four-Year Survival Data Presented at ASTRO 2009
11/2/2009
More...
|
YM BioSciences (YM.TO) Reports Additional Results from NIMOTUZUMAB PHASE III Study
10/30/2009
More...
|
VIVUS, Inc. (VVUS): Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
10/30/2009
More...
|
Genta Incorporated (GETA.OB) Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma, Trial Fails to Meet Primary Endpoint; Stock Down 70.0% at Market Close
10/30/2009
More...
|
Roche (RHHBY) (JOBS), Ipsen (JOBS) Diabetes Drug Meets Late-Stage Target
10/30/2009
More...
|
Dynavax Technologies Corporation (DVAX)’s HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease Patients
10/30/2009
More...
|
Miltenyi Biotec, Inc.: Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
10/29/2009
More...
|
Cardiome Pharma Corp. (COM.TO) And Astellas Pharma Inc. Announce Initiation Of Patient Enrolment In ACT 5 Trial
10/29/2009
More...
|
Genta Incorporated (GNTA) Announces Conference Call to Review Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
10/29/2009
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients
10/29/2009
More...
|
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) (JOBS) Commence Phase III Horizon Program to Develop a Next-Generation Treatment for COPD
10/28/2009
More...
|
Elan Corporation PLC (ELN) and Biogen Idec, Inc. (Massachusetts) (BIIB) Release: Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn’s Disease
10/28/2009
More...
|
Biomoda Prepares for Phase III Clinical Trials
10/28/2009
More...
|
Hyperion Therapeutics Announces First Patient Enrolled in Pivotal Trial in Patients With Urea Cycle Disorders
10/27/2009
More...
|
Celsion Corporation (CLN) and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
10/27/2009
More...
|
New Data From Arena Pharmaceuticals, Inc. (ARNA)'s Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life
10/27/2009
More...
|
Orexigen Therapeutics, Inc. (OREX) Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The The Obesity Society
10/27/2009
More...
|
Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
10/26/2009
More...
|
Potential of Lux Biosciences' LUVENIQ (LX211) as First Disease Modifying Treatment for Sight-Threatening Non-Infectious Uveitis Highlighted at American Academy of Ophthalmology
10/26/2009
More...
|
Positive Data from Two Investigator-Initiated Studies with Santarus Inc. (SNTS)' ZEGERID to Be Presented At American College of Gastroenterology
10/26/2009
More...
|
EpiCept Corporation (EPCT) Release: New Data Supports Pharmacoeconomic Benefits of Ceplene(R)
10/26/2009
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: Data Demonstrate That GATTEX(TM) (Teduglutide) Improves Lean Body Mass, Mineral Composition and Electrolyte Levels in Patients with Parenteral Nutrition Dependent Short Bowel Syndrome
10/26/2009
More...
|
Orexigen Therapeutics, Inc. (OREX) Obesity Drug Shows Added Benefits
10/26/2009
More...
|
Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson's Disease
10/26/2009
More...
|
Positive Data from Arena Pharmaceuticals, Inc. (ARNA)'s Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
10/26/2009
More...
|
Cempra Pharmaceuticals, Inc. Will Present New Data on cem-101 and cem-102 at the Infectious Diseases Society of America
10/23/2009
More...
|
Bayer Corporation (BAY) and Onyx Pharmaceuticals, Inc. (ONXX) Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
10/23/2009
More...
|
Mixed Data for AstraZeneca PLC (AZN) (JOBS) and Bristol-Myers Squibb Company (BMY) (JOBS) Diabetes Drug in New Phase III Study
10/23/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS), GlaxoSmithKline (GSK) Report Progress With Lupus Treatment
10/22/2009
More...
|
Kowa Company: Study Demonstrates LIVALO(R) Is an Efficacious Treatment for Achieving Lipid Goals LIVALO Superior to Simvastatin in Reducing LDL-C When Comparing Starting Doses
10/22/2009
More...
|
Halozyme Therapeutics, Inc. (HALO) Announces Roche (RHHBY) Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin(R)
10/22/2009
More...
|